ID   ZCCHV_RAT               Reviewed;         776 AA.
AC   Q8K3Y6;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   02-OCT-2024, entry version 120.
DE   RecName: Full=Zinc finger CCCH-type antiviral protein 1;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 13;
DE            Short=ARTD13;
DE   AltName: Full=Inactive Poly [ADP-ribose] polymerase 13 {ECO:0000305};
DE            Short=PARP13;
DE   AltName: Full=Zinc finger antiviral protein;
DE            Short=ZAP;
DE            Short=rZAP;
GN   Name=Zc3hav1; Synonyms=Zap;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12215647; DOI=10.1126/science.1074276;
RA   Gao G., Guo X., Goff S.P.;
RT   "Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger
RT   protein.";
RL   Science 297:1703-1706(2002).
RN   [2]
RP   PROTEIN SEQUENCE OF 227-238; 341-349; 359-371 AND 548-562, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Lubec G., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   FUNCTION.
RX   PubMed=14557641; DOI=10.1128/jvi.77.21.11555-11562.2003;
RA   Bick M.J., Carroll J.W., Gao G., Goff S.P., Rice C.M., McDonald M.R.;
RT   "Expression of the zinc-finger antiviral protein inhibits alphavirus
RT   replication.";
RL   J. Virol. 77:11555-11562(2003).
RN   [4]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND NUCLEAR EXPORT
RP   SIGNAL.
RX   PubMed=15358138; DOI=10.1016/j.bbrc.2004.06.174;
RA   Liu L., Chen G., Ji X., Gao G.;
RT   "ZAP is a CRM1-dependent nucleocytoplasmic shuttling protein.";
RL   Biochem. Biophys. Res. Commun. 321:517-523(2004).
RN   [5]
RP   RNA-BINDING.
RX   PubMed=15542630; DOI=10.1128/jvi.78.23.12781-12787.2004;
RA   Guo X., Carroll J.-W., McDonald M.R., Goff S.P., Gao G.;
RT   "The zinc finger antiviral protein directly binds to specific viral mRNAs
RT   through the CCCH zinc finger motifs.";
RL   J. Virol. 78:12781-12787(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=17182693; DOI=10.1128/jvi.01601-06;
RA   Mueller S., Moeller P., Bick M.J., Wurr S., Becker S., Guenther S.,
RA   Kuemmerer B.M.;
RT   "Inhibition of filovirus replication by the zinc finger antiviral
RT   protein.";
RL   J. Virol. 81:2391-2400(2007).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH EXOSC5.
RX   PubMed=17185417; DOI=10.1073/pnas.0607063104;
RA   Guo X., Ma J., Sun J., Gao G.;
RT   "The zinc-finger antiviral protein recruits the RNA processing exosome to
RT   degrade the target mRNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:151-156(2007).
RN   [8]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17928353; DOI=10.1128/jvi.00402-07;
RA   MacDonald M.R., Machlin E.S., Albin O.R., Levy D.E.;
RT   "The zinc finger antiviral protein acts synergistically with an interferon-
RT   induced factor for maximal activity against alphaviruses.";
RL   J. Virol. 81:13509-13518(2007).
RN   [9]
RP   FUNCTION.
RX   PubMed=18225958; DOI=10.1371/journal.pgen.0040021;
RA   Kerns J.A., Emerman M., Malik H.S.;
RT   "Positive selection and increased antiviral activity associated with the
RT   PARP-containing isoform of human zinc-finger antiviral protein.";
RL   PLoS Genet. 4:E21-E21(2008).
RN   [10]
RP   INTERACTION WITH DDX17.
RX   PubMed=18334637; DOI=10.1073/pnas.0712276105;
RA   Chen G., Guo X., Lv F., Xu Y., Gao G.;
RT   "p72 DEAD box RNA helicase is required for optimal function of the zinc-
RT   finger antiviral protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4352-4357(2008).
RN   [11]
RP   SUBUNIT, AND MUTAGENESIS OF CYS-88.
RX   PubMed=20181706; DOI=10.1128/jvi.02018-09;
RA   Law L.M., Albin O.R., Carroll J.W., Jones C.T., Rice C.M., Macdonald M.R.;
RT   "Identification of a dominant negative inhibitor of human zinc finger
RT   antiviral protein reveals a functional endogenous pool and critical
RT   homotypic interactions.";
RL   J. Virol. 84:4504-4512(2010).
RN   [12]
RP   INTERACTION WITH DHX30.
RX   PubMed=21204022; DOI=10.1007/s13238-010-0117-8;
RA   Ye P., Liu S., Zhu Y., Chen G., Gao G.;
RT   "DEXH-Box protein DHX30 is required for optimal function of the zinc-finger
RT   antiviral protein.";
RL   Protein Cell 1:956-964(2010).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH EXOSC5.
RX   PubMed=21876179; DOI=10.1073/pnas.1101676108;
RA   Zhu Y., Chen G., Lv F., Wang X., Ji X., Xu Y., Sun J., Wu L., Zheng Y.T.,
RA   Gao G.;
RT   "Zinc-finger antiviral protein inhibits HIV-1 infection by selectively
RT   targeting multiply spliced viral mRNAs for degradation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:15834-15839(2011).
RN   [14]
RP   PHOSPHORYLATION AT SER-257; SER-262; SER-266; SER-270 AND SER-274.
RX   PubMed=22514281; DOI=10.1074/jbc.m111.306373;
RA   Sun L., Lv F., Guo X., Gao G.;
RT   "Glycogen synthase kinase 3? (GSK3?) modulates antiviral activity of zinc-
RT   finger antiviral protein (ZAP).";
RL   J. Biol. Chem. 287:22882-22888(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266; SER-270; SER-274 AND
RP   SER-325, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-225, SUBUNIT, RNA-BINDING, AND
RP   DOMAIN N-TERMINAL.
RX   PubMed=22407013; DOI=10.1038/nsmb.2243;
RA   Chen S., Xu Y., Zhang K., Wang X., Sun J., Gao G., Liu Y.;
RT   "Structure of N-terminal domain of ZAP indicates how a zinc-finger protein
RT   recognizes complex RNA.";
RL   Nat. Struct. Mol. Biol. 19:430-435(2012).
CC   -!- FUNCTION: Antiviral protein which inhibits the replication of viruses
CC       by recruiting the cellular RNA degradation machineries to degrade the
CC       viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the
CC       target viral mRNA, recruits cellular poly(A)-specific ribonuclease PARN
CC       to remove the poly(A) tail, and the 3'-5' exoribonuclease complex
CC       exosome to degrade the RNA body from the 3'-end. It also recruits the
CC       decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove
CC       the cap structure of the viral mRNA to initiate its degradation from
CC       the 5'-end. Its target viruses belong to families which include
CC       retroviridae: human immunodeficiency virus type 1 (HIV-1) and moloney
CC       and murine leukemia virus (MoMLV), filoviridae: ebola virus (EBOV) and
CC       marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river
CC       virus (RRV). Specifically targets the multiply spliced but not
CC       unspliced or singly spliced HIV-1 mRNAs for degradation.
CC       {ECO:0000269|PubMed:12215647, ECO:0000269|PubMed:14557641,
CC       ECO:0000269|PubMed:17182693, ECO:0000269|PubMed:17185417,
CC       ECO:0000269|PubMed:17928353, ECO:0000269|PubMed:18225958,
CC       ECO:0000269|PubMed:21876179}.
CC   -!- SUBUNIT: Homodimer or homooligomer. Homooligomerization is essential
CC       for its antiviral activity. Interacts with EXOSC5. Interacts with
CC       EXOSC3, EXOSC7, DCP2 and DCP1A (By similarity). Interacts with PARN in
CC       an RNA-independent manner (By similarity). Interacts with XRN1 in an
CC       RNA-dependent manner (By similarity). Interacts (via N-terminal domain)
CC       with DHX30 (via N-terminus) in an RNA-independent manner. Interacts
CC       (via N-terminal domain) with DDX17 in an RNA-independent manner.
CC       {ECO:0000250, ECO:0000269|PubMed:17185417, ECO:0000269|PubMed:18334637,
CC       ECO:0000269|PubMed:20181706, ECO:0000269|PubMed:21204022,
CC       ECO:0000269|PubMed:21876179, ECO:0000269|PubMed:22407013}.
CC   -!- INTERACTION:
CC       Q8K3Y6; Q8K3Y6: Zc3hav1; NbExp=3; IntAct=EBI-8860250, EBI-8860250;
CC       Q8K3Y6; Q92841: DDX17; Xeno; NbExp=6; IntAct=EBI-8860250, EBI-746012;
CC       Q8K3Y6; Q9NQT5: EXOSC3; Xeno; NbExp=3; IntAct=EBI-8860250, EBI-371866;
CC       Q8K3Y6; Q9NQT4: EXOSC5; Xeno; NbExp=6; IntAct=EBI-8860250, EBI-371876;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15358138,
CC       ECO:0000269|PubMed:17928353}. Nucleus {ECO:0000269|PubMed:15358138}.
CC       Note=Localizes in the cytoplasm at steady state, but shuttles between
CC       nucleus and cytoplasm in a XPO1-dependent manner.
CC       {ECO:0000269|PubMed:15358138}.
CC   -!- TISSUE SPECIFICITY: Expressed in the kidney and liver.
CC       {ECO:0000269|PubMed:12215647}.
CC   -!- INDUCTION: By type I interferon (IFN) and viruses.
CC       {ECO:0000269|PubMed:17928353}.
CC   -!- DOMAIN: The N-terminal domain is sufficient to bind to viral RNAs and
CC       promote their degradation. The second and fourth zinc fingers are
CC       involved in binding to specific viral RNAs. Contains a divergent PARP
CC       homology ADP-ribosyltransferase domain which lacks the structural
CC       requirements for NAD[+] binding. It is therefore inactive.
CC       {ECO:0000250|UniProtKB:Q7Z2W4}.
CC   -!- PTM: Phosphorylation at Ser-274 is essential for sequential
CC       phosphorylation of Ser-270, Ser-266, Ser-262 and Ser-257 by GSK3-beta.
CC       Phosphorylation by GSK3-beta enhances its antiviral activity.
CC       {ECO:0000269|PubMed:22514281}.
CC   -!- SIMILARITY: Belongs to the ARTD/PARP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF521008; AAM75358.1; -; mRNA.
DR   PDB; 3U9G; X-ray; 1.80 A; A=1-225.
DR   PDBsum; 3U9G; -.
DR   AlphaFoldDB; Q8K3Y6; -.
DR   SMR; Q8K3Y6; -.
DR   DIP; DIP-29842N; -.
DR   IntAct; Q8K3Y6; 7.
DR   STRING; 10116.ENSRNOP00000018782; -.
DR   iPTMnet; Q8K3Y6; -.
DR   PhosphoSitePlus; Q8K3Y6; -.
DR   jPOST; Q8K3Y6; -.
DR   PaxDb; 10116-ENSRNOP00000018782; -.
DR   UCSC; RGD:628694; rat.
DR   AGR; RGD:628694; -.
DR   RGD; 628694; Zc3hav1.
DR   eggNOG; ENOG502QSC4; Eukaryota.
DR   InParanoid; Q8K3Y6; -.
DR   PhylomeDB; Q8K3Y6; -.
DR   EvolutionaryTrace; Q8K3Y6; -.
DR   PRO; PR:Q8K3Y6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; ISO:RGD.
DR   GO; GO:0098586; P:cellular response to virus; IMP:RGD.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0050691; P:regulation of defense response to virus by host; IDA:RGD.
DR   GO; GO:0009615; P:response to virus; IDA:UniProtKB.
DR   Gene3D; 3.30.720.50; -; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR051712; ARTD-AVP.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR004170; WWE_dom.
DR   InterPro; IPR037197; WWE_dom_sf.
DR   InterPro; IPR041360; ZAP_HTH.
DR   InterPro; IPR040954; Znf-CCCH_8.
DR   InterPro; IPR000571; Znf_CCCH.
DR   PANTHER; PTHR45740; POLY [ADP-RIBOSE] POLYMERASE; 1.
DR   PANTHER; PTHR45740:SF8; ZINC FINGER CCCH-TYPE ANTIVIRAL PROTEIN 1; 1.
DR   Pfam; PF18606; HTH_53; 1.
DR   Pfam; PF02825; WWE; 1.
DR   Pfam; PF18633; zf-CCCH_8; 1.
DR   SUPFAM; SSF117839; WWE domain; 1.
DR   PROSITE; PS50918; WWE; 1.
DR   PROSITE; PS50103; ZF_C3H1; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Cytoplasm;
KW   Direct protein sequencing; Immunity; Innate immunity; Metal-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; RNA-binding; Zinc;
KW   Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   CHAIN           2..776
FT                   /note="Zinc finger CCCH-type antiviral protein 1"
FT                   /id="PRO_0000211344"
FT   DOMAIN          671..758
FT                   /note="WWE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00248"
FT   ZN_FING         73..86
FT                   /note="C3H1-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   ZN_FING         88..110
FT                   /note="C3H1-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   ZN_FING         150..172
FT                   /note="C3H1-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   ZN_FING         169..193
FT                   /note="C3H1-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00723"
FT   REGION          2..254
FT                   /note="N-terminal domain"
FT   REGION          221..249
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          224..254
FT                   /note="Binding to EXOSC5"
FT   REGION          308..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          457..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          512..562
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           69..76
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:15358138"
FT   MOTIF           284..291
FT                   /note="Nuclear export signal"
FT   MOTIF           405..406
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        228..245
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        308..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        339..354
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   MOD_RES         257
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:22514281"
FT   MOD_RES         262
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:22514281"
FT   MOD_RES         266
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:22514281,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         270
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000269|PubMed:22514281,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         274
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22514281,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         278
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UPF5"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   MOD_RES         501
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UPF5"
FT   MOD_RES         544
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UPF5"
FT   MOD_RES         667
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7Z2W4"
FT   MUTAGEN         88
FT                   /note="C->R: Results in a non-functional protein with a
FT                   dominant negative phenotype."
FT                   /evidence="ECO:0000269|PubMed:20181706"
FT   HELIX           9..16
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   TURN            17..19
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   STRAND          20..22
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           23..30
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           34..44
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   TURN            46..48
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   STRAND          49..53
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   STRAND          62..66
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           89..92
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           97..99
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           115..123
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           131..139
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           143..145
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   STRAND          163..166
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           175..178
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           196..205
FT                   /evidence="ECO:0007829|PDB:3U9G"
FT   HELIX           209..223
FT                   /evidence="ECO:0007829|PDB:3U9G"
SQ   SEQUENCE   776 AA;  86771 MW;  D13F61A9F8E5B552 CRC64;
     MADPGVCCFI TKILCAHGGR MTLEELLGEI RLPEAQLYEL LETAGPDRFV LLETGGQAGI
     TRSVVATTRA RVCRRKYCQR PCDSLHLCKL NLLGRCHYAQ SQRNLCKYSH DVLSEQNFQI
     LKNHELSGLN QEELACLLVQ SDPFFLPEIC KSYKGEGRKQ TCGQPQPCER LHICEHFTRG
     NCSYLNCLRS HNLMDRKVLT IMREHGLSPD VVQNIQDICN NKHARRNPPG TRAAHPHRRG
     GAHRDRSKSR DRFLHNSLEF LSPVVSPLGS GPPSPDVTSC KDSLEDVSVD VTQKFKYLGT
     HDRAQLSPVS SKAAGVQGPS QMRASQEFSE DGNLDDIFSR NRSDSSSSRA SAAKVAQRNE
     AVAMKMGMEV KGKKEAPDID RVPFLNSYID GVTMEKASVS GIPGKKFTAN DLENLLLLND
     TWKNVAKPQD LQTTGRITDS GQDKAFLQNK YGGNPVWASA STHNAPNGSS QIMDETPNVS
     KSSTSGFAIK PAIAGGKEAV YSGVQSPRSQ VLAVPGEATT PVQSNRLPQS PLSSSSHRAA
     ASGSPGKNST HTSVSPAIES SRMTSDPDEY LLRYILNPLF RMDNHGPKEI CQDHLYKGCQ
     QSHCDRSHFH LPYRWQMFVY TTWRDFQDME SIEQAYCDPH VELILIENHQ INFQKMTCDS
     YPIRRLSTPS YEEKPLSAVF ATKWIWYWKN EFNEYIQYGN ESPGHTSSDI NSAYLESFFQ
     SCPRGVLPFQ AGSQKYELSF QGMIQTNIAS KTQRHVVRRP VFVSSNDVEQ KRRGPE
//
